Back to Browse Journals

Clinical Pharmacology: Advances and Applications

Professor Frankel

Department of Hematology/Oncology, SouthWestern Medical Center, United States

Professor Frankel

Editor-in-Chief:  Professor Arthur E. Frankel

Dr. Arthur Frankel is a professor at the Department of Internal Medicine, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center.

Dr. Frankel earned his MD from Harvard Medical School and conducted his medicine internship at Yale University. Soon after completing his degree, Dr. Frankel began as a research scientist with the National Institute of Health and later completed his medicine residency and oncology fellowship at Stanford University. He is board certified in internal medicine, medical oncology and hematology. Dr. Frankel is a member of the American Society of Clinical Oncology, American Society of Hematology and American Association of Cancer Research.

Dr. Frankel's main focus is combining the clinical practice of hematology/oncology with an investigative cancer drug development program to better move targeted cancer therapeutics into the clinical setting. He has participated in the development of targeted peptide toxins also called immunotoxins for melanoma, breast cancer, ovarian cancer, leukemia, lymphoma, chronic pain, prostate cancer, and thyroid cancer. He has performed phase I clinical trials for many of these agents. He has over 190 peer-reviewed articles, has edited three books, organized for international symposia and received grants from the American Cancer Society, the Leukemia and Lymphoma Society, NIH and the Van Andel Foundation.

Dr Murthy

Pharmaceutics, University of Mississippi, United States

Dr Murthy

Associate Editor: Dr S Narasimha Murthy

Dr S Narasimha Murthy is an Associate Professor of Pharmaceutics at the University of Mississippi. His Masters and Ph.D research at Bangalore University, India, focused on Development of Transdermal Drug Delivery Systems for prolonged delivery of antiasthmatic drugs. During his postdoctoral research at the Roswell Park Cancer Institute, Buffalo, NY, USA.  Dr Murthy worked on active dermal and transdermal drug delivery techniques such as iontophoresis and electroporation.

His Research group ( at the University of Mississippi continues to work on the development of novel formulations and technologies for the drug delivery into skin and nail apparatus.

Dr Murthy has published over 50 research papers in peer-reviewed journals and presented over 70 papers in various national and international scientific conferences. He has edited two textbooks titled “Dermatokinetics of Therapeutic agents” and “Ungual and Trans-Ungual delivery of Drugs”.  He regularly serves as reviewer of grant proposals for International Research Foundations and National Institutes of Health, USA.  He is currently serving as manuscript reviewer and Editorial Board member in about twenty pharmaceutical journals. He also has several awards and recognitions to his credit. He is a member of Controlled Release Society and Chair-Elect of Dermatopharmaceutics focus group of American Association of Pharmaceutical Scientists.

Editorial Board

William C. Cho, Ph.D., Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong

James M. Cook, University Distinguished Professor, Organic Chemistry, Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, USA

Esam Z. Dajani, President, IDDC Corporation; Adjunct Professor of Medicine, Loyola University-Chicago, Chicago, Illinois, USA

Nicholas S. Duesbery, Deputy Director for Research Operations and Senior Scientific Investigator of the Laboratory of Cancer and Developmental Cell Biology, Van Andel Institute, Grand Rapids, MI, USA

M. Elizabeth Fini, Director, Institute for Genetic Medicine, Professor of Cell and Neurobiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA

Laura J. Frishman, Professor of Optometry, Vision Science and Biology, Moores Professor, Associate Dean, College of Optometry, University of Houston, Calhoun, Houston, TX, USA

Hendrik Fuchs, Professor for Target Cell Directed Tumor Therapy, Head of the Laboratory of Molecular Tumor Therapy and Deputy Director of the Central Department of Laboratory Medicine and Pathobiochemistry, Charité - Universitätsmedizin Berlin, Germany

Ramesh Ganju, Scott Endowed Professor of Pathology, Vice-Chair Experimental Pathology, Ohio State University, Columbus, OH, USA

Paul L Kaufman, Ernst H. Bárány Professor of Ocular Pharmacology, Department Chair Emeritus, Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Robert J. Kreitman, Chief, Clinical Immunotherapy Section, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Macus Tien Kuo, Felix Haas Professor, Department of Translational Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Edythe D. London PhD. Katherine K. and Thomas P. Pike Professor of Addiction Studies, Professor of Psychiatry, and Professor of Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, USA

William G. North, Professor of Physiology, Dartmouth Medical School, Hanover, NH, USA

Hui-Lin Pan, Helen T. Hawkins Distinguished Professor and Deputy Division Head for Research, Department of Anesthesiology and Perioperative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Bruce G. Pollock, Professor of Psychiatry & Pharmacology, and Director, Division of Geriatric Psychiatry, University of Toronto, Faculty of Medicine, Vice President Research and Director, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada

Eva E. Redei, Ph.D.David Lawrence Stein Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University

Scot C. Remick, MD, Physician Leader Oncology Service Line, MaineHealth'; Chief, Oncology Services, Maine Medical Center, USA

Mandip Singh Sachdeva, Professor, Pharmaceutics, College of Pharmacy, Florida A&M University, FL, USA

Stephen H. Safe, Distinguished Professor, Department of Veterinary Physiology and Pharmacology, Director, Center for Environmental and Genetic Medicine, Institute of Biosciences and Technology, Texas A&M University and Health Science Center, College Station, TX, USA

J. Philip Saul, Professor of Pediatrics, Medical University of South Carolina, Charleston, SC, USA

Alan D. Stiles, Brewer Distinguished Professor and Chair, Department of Pediatrics, Physician-in-Chief, NC Children's Hospital, University of North Carolina, Chapel Hill, NC, USA

Daniel A. Vallera, Professor of Therapeutic Radiology - Radiation Oncology, Lion Scholar and Director, Section on Molecular Cancer Therapeutics, University of Minnesota Cancer Center, Minnesota, USA

John van den Anker, Professor, Children's National Medical Center, Washington, D.C., USA

Donna Wang, Distinguished Professor, Chief, Division of Nanomedicine and Molecular Intervention, Michigan State University, East Lansing, Michigan, USA

Jung Hee Woo, Associate Director, Cancer Research Institute, Department of Internal Medicine, Scott and White Memorial Hospital, College of Medicine, Texas A&M University System Health Science Center, Temple, TX, USA